VEGFA and melanoma: The inhibition of VEGF (the main pro-angiogenic factor of melanoma) was identified as an alternative approach for the treatment of HMM, and several anti-angiogenic drugs have been approved by the FDA for the treatment of various solid cancers (Table 2).